ESLA
Estrella Immunopharma, Inc.$0.9190 −0.07 (−6.70%)
Oct 26 4:00 PM ET · prev $0.9850
Market cap
$31.6M
Nano cap
Median target
$12.00
+1206% · range $12.00–12.00
Next earnings
Nov 10
in 14 days · EPS est. −$0.08
1 year
−59.7%
from $2.28 · Oct 27
30 days
+113.2%
from $0.4310
52-week range
$0.3140–3.05
−70% from high · low Oct 13
Avg volume 20D
5.55M
Oct 15 spike 63.11M
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Aug 14 Short interest jumps 27.8% to 61.4K
- X Aug 31 Short interest jumps 90.7% to 117.1K
- X Sep 15 Short interest jumps 31.3% to 153.8K
- X Sep 30 Short interest jumps 39.2% to 214.0K
- E Oct 15 Trading halt: Halt Resumed: ESLA — trading resumed after LUDP (Volatilit…
- E Oct 15 Trading halt: Trading Halt: ESLA — LUDP (Volatility Trading Pause)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 2 trimmed or exited.
- TrendUPTREND
58% above its 50-day average.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | ADD | $54.1K |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $40.7K |
| NORTHERN TRUST CORP | ADD | $36.3K |
| UBS Group AG | NEAR_EXIT | $1.8K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $166.9K |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $66.6K |
| BlackRock, Inc. | ADD | $42.3K |
| UBS Group AG | DOUBLED | $16.0K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Feb 202612-month targets · 1 analysts
$0.9190 $12.00 $12.00 $12.00
Price is below the lowest target. Median implies +1206%.Targets as of Oct 27, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Feb 9, 2026 | D. Boral Capital MAINTAIN | Buy |
| Jan 28, 2026 | D. Boral Capital MAINTAIN | Buy |
| Nov 3, 2025 | D. Boral Capital MAINTAIN | Buy |
| Aug 12, 2025 | D. Boral Capital MAINTAIN | Buy |
| Jun 3, 2025 | D. Boral Capital MAINTAIN | Buy |
| May 29, 2025 | D. Boral Capital MAINTAIN | Buy |
Insider ledger
Form 4$0
open-market buys or sells · 12 mo
| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 25, 2026 | Liu Cheng CEO | EXERCISE | $81.5K |
| Aug 18, 2026 | Xu Jiandong Chief Financial Officer | EXERCISE | $81.5K |
| Oct 7, 2025 | Xu Jiandong Chief Financial Officer | BUY | $1.3K |
| Sep 22, 2025 | Xu Jiandong Chief Financial Officer | BUY | $1.2K |
| Sep 11, 2025 | Xu Jiandong Chief Financial Officer | BUY | $104.00 |
Earnings setup
EstimatesNov 10
reports in 14 days
−$0.08
EPS estimate, this quarter
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
$0.00090d
$0.00060d
−$0.08030d
−$0.0807d
−$0.080Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.08 | -$0.08–-$0.08 | +0.0% | $0.00 |
| Next Q | -$0.07 | -$0.07–-$0.07 | +0.0% | $0.00 |
| Current FY | -$0.29 | -$0.29–-$0.29 | +25.6% | $0.00 |
| Next FY | -$0.32 | -$0.32–-$0.32 | +0.0% | $0.00 |
Reddit
Recent comments
Fresh comment, for subscribers
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Trading halts
| Oct 15, 2026 | Volatility Pause | Resumed |
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 Trading halt
Halt Resumed: ESLA — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-15T19:05:44.000Z | Resumed 2026-10-15T19:10:44.000Z
Aug 25, 2026 Insider
Liu Cheng acquired via exercise 100,000 shares
CEO @ $0.8150 ($81.5K)
Aug 18, 2026 Insider
Xu Jiandong acquired via exercise 100,000 shares
Chief Financial Officer @ $0.8150 ($81.5K)
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
52,033 shares ($54.1K)
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
39,100 shares ($40.7K)
Oct 7, 2025 Insider
Xu Jiandong bought 1,000 shares
Chief Financial Officer @ $1.33 ($1.3K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 15, 2026
Trading halt
Halt Resumed: ESLA — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-15T19:05:44.000Z | Resumed 2026-10-15T19:10:44.000Z
Oct 15, 2026
Trading halt
Trading Halt: ESLA — LUDP (Volatility Trading Pause)
Estrella Immunopharma Cmn | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Aug 24, 2026
Listing
Listing Status: ESLA — Deficient (was Normal)
Estrella Immunopharma, Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Jul 6, 2026
Listing
Listing Status: ESLA — Normal (was Deficient)
Estrella Immunopharma, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N